|
ARMCX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47510000003681E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53590000051551E-07 |
| Normal-vs-Stage2 |
1.833990E-02 |
| Normal-vs-Stage3 |
9.839500E-03 |
| Normal-vs-Stage4 |
6.826700E-04 |
| Stage1-vs-Stage2 |
7.818600E-01 |
| Stage1-vs-Stage3 |
1.322190E-01 |
| Stage1-vs-Stage4 |
8.869200E-01 |
| Stage2-vs-Stage3 |
4.621000E-01 |
| Stage2-vs-Stage4 |
7.991000E-01 |
| Stage3-vs-Stage4 |
2.685400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22190052415294E-10 |
| Normal-vs-AfricanAmerican |
4.556600E-03 |
| Normal-vs-Asian |
9.557700E-03 |
| Caucasian-vs-AfricanAmerican |
4.655000E-01 |
| Caucasian-vs-Asian |
9.234000E-01 |
| AfricanAmerican-vs-Asian |
7.849200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62647673107585E-12 |
| Normal-vs-Female |
3.935800E-02 |
| Male-vs-Female |
4.582600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.600400E-02 |
| Normal-vs-Extreme_Weight |
1.590505505078E-11 |
| Normal-vs-Obese |
1.766940E-04 |
| Normal-vs-Extreme_Obese |
1.9433999998153E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.519900E-02 |
| Normal_Weight-vs-Obese |
5.382200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.081800E-02 |
| Extreme_Weight-vs-Obese |
6.707900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.200400E-01 |
| Obese-vs-Extreme_Obese |
5.274300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.023600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.4904999999964E-05 |
| Normal-vs-Age(61-80Yrs) |
1.99720000537695E-08 |
| Normal-vs-Age(81-100Yrs) |
1.710839999991E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.055400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.825850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.374600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.243010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.168300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.302400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12719833467168E-11 |
| Normal-VS-Type2 PRCC |
1.024190E-03 |
| Normal-VS-KIRP CIMP |
1.854840E-01 |
| Normal-VS-Unclassified PRCC |
4.14240000000676E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.944220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.076200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.095700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.801200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.099200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.139000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30340002416574E-09 |
| Normal-vs-N1 |
9.051700E-02 |
| Normal-vs-N2 |
4.324000E-01 |
| N0-vs-N1 |
7.761900E-02 |
| N0-vs-N2 |
6.056000E-02 |
| N1-vs-N2 |
7.952200E-01 |
|
|
